Inside the Green Party’s Plan to Legalise Drugs

In this episode, we are joined by Dr. Carrie Hamilton and Michael Wakelyn-Green, from the Green Party Drug Policy Working Group, to explore the party's proposed approach to drug policy. With recent focus on their long-term plan to legalise and regulate all drugs in the UK, we discuss how different drugs would be regulated and how the party would navigate obstacles including contravening UN conventions.

We also dive into some of the party's short-term policies that could be implemented within the current legislative framework, including establishing more UK-based overdose prevention centres, to decriminalising the personal possession of cannabis.

If you have been affected by the issues discussed in this episode, please visit barod.cymru and confidentially chat to a trained support worker via Barod's Live Webchat Service, that is open 7-days a week, or call Dan 24/7, Wales' national drug and alcohol helpline on 0808 808 2234 or text DAN to 81066.Contents of the video:

(00:00) Highlights of the episode

(01:26) Introduction

(05:27) Short-term policies under the current legislative framework

(14:55) Decriminalisation vs legalisation

(23:01) How would different drugs be regulated?

(28:59) How would the money raised by a legally regulated market be redistributed?

(32:46) Overcoming UN conventions

(38:44) Responding to others saying legalising drugs send out the wrong message

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(62)

What is sober curiosity? With Scott Woolley (Arclett)

What does it mean to question our relationship with alcohol? Founder and Director of Arclett, Scott Woolley, joins Drugs Unwrapped to share his personal journey to becoming alcohol-free and explore th...

29 Syys 37min

Bringing young people's voices to the drug policy table with Ruby Rose Lawlor

We are joined by YouthRise's Executive Director, Ruby Rose Lawlor, to discuss influencing drug policy change at the UN, full spectrum harm reduction and the recent recommendation to decriminalise drug...

14 Syys 52min

Developing digital infrastructure within harm reduction with Mark Tudor

In this episode, we are joined by Mark Tudor, co-founder of Substancy. Mark has worked in the harm reduction field for over 30 years, but most recently has established Substancy, a social enterprise t...

1 Heinä 30min

What is trauma-informed practice?

We are joined by Sarah, CAVDAS Alliance Manager, to shed light on what trauma-informed practice is and why it matters. Sarah has led Barod's journey towards becoming a trauma-informed organisation and...

17 Kesä 37min

Image and Performance Enhancing Drugs: What's the appeal?

In this episode, we are joined by Liberty Musungo, Image and Performance Enhancing Drugs (IPEDs) Lead for Dyfed Drug and Alcohol Service (DDAS). Liberty takes us through what IPEDs are and how they wo...

2 Kesä 45min

How do we become anti-stigma?

In this Learning at Work Week special, we are joined by Barod's Operations Manager, Sian, to discuss how we can move from being non-stigmatising, to actively challenging and becoming anti-stigma.In th...

19 Touko 23min

Drugs on the brain with Professor David Nutt

In this episode, we’re joined by leading neuropsychopharmacologist, Professor David Nutt, for a deep dive into the human brain and its relationship with drugs. We discuss whether our brains are built ...

25 Maalis 54min